Literature DB >> 18595142

Reduced expression of P120 catenin in cholangiocarcinoma correlated with tumor clinicopathologic parameters.

Bo Zhai1, He-Xin Yan, Shu-Qin Liu, Lei Chen, Meng-Chao Wu, Hong-Yang Wang.   

Abstract

AIM: To investigate the relationship between the expression of P120 and the clinicopathologic parameters in intrahepatic cholangiocarcinoma (ICC).
METHODS: An immunohistochemical study of E-cadherin and P120 catenin was performed on 42 specimens of ICC with a Dako Envision kit.
RESULTS: The expression of E-cadherin and P120 was reduced in 27 cases (64.3%) and 31 cases (73.8%), respectively. Both E-cadherin and P120 expressions were significantly correlated with the tumor histological grade (chi2 = 9.333, P = 009 and chi2 = 11.71, P = 0.003), TNM stage (chi2= 8.627, P = 0.035 and chi2 = 13.123, P = 0.004), intrahepatic metastasis (chi2= 7.292, P = 0.007 and chi2 = 4.657, P = 0.041, respectively) and patients' survival (chi2= 6.351, P = 0.002 and chi2 = 4.023, P = 0.000, respectively). In addition, the expression of P120 was in concordance with that of E-cadherin (chi2 = 13.797, P = 0.000), indicating that the expression of P120 may be dependent on that of E-cadherin. Finally, only P120 expression was found to be an independent prognostic factor in Cox regression model (r = 0.088, P = 0.049).
CONCLUSION: Down-regulated expression of E-cadherin and P120 occurs frequently in ICC and contributes to the progression and development of tumor. Both of them may be valuable biologic markers for predicting tumor invasion, metastasis and patients' survival, but only P120 is an independent prognostic factor for ICC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18595142      PMCID: PMC2719238          DOI: 10.3748/wjg.14.3739

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  27 in total

1.  The mode of tumour progression in combined hepatocellular carcinoma and cholangiocarcinoma: an immunohistochemical analysis of E-cadherin, alpha-catenin and beta-catenin.

Authors:  Yoshiki Asayama; Ken-ichi Taguchi Ki; Shin-ichi Aishima Si; Hidehiro Nishi; Kouji Masuda; Masazumi Tsuneyoshi
Journal:  Liver       Date:  2002-02

2.  Up-regulation, nuclear import, and tumor growth stimulation of the adhesion protein p120 in pancreatic cancer.

Authors:  Julia Mayerle; Helmut Friess; Markus W Büchler; Jürgen Schnekenburger; Frank U Weiss; Klaus-P Zimmer; Wolfram Domschke; Markus M Lerch
Journal:  Gastroenterology       Date:  2003-04       Impact factor: 22.682

Review 3.  The role of the E-cadherin/catenin adhesion complex in the development and progression of cancer.

Authors:  F Nollet; G Berx; F van Roy
Journal:  Mol Cell Biol Res Commun       Date:  1999-08

4.  Altered expression of beta-catenin without genetic mutation in intrahepatic cholangiocarcinoma.

Authors:  K Sugimachi; K Taguchi; S Aishima; S Tanaka; M Shimada; K Kajiyama; K Sugimachi; M Tsuneyoshi
Journal:  Mod Pathol       Date:  2001-09       Impact factor: 7.842

5.  High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer.

Authors:  R M Bremnes; R Veve; E Gabrielson; F R Hirsch; A Baron; L Bemis; R M Gemmill; H A Drabkin; W A Franklin
Journal:  J Clin Oncol       Date:  2002-05-15       Impact factor: 44.544

6.  Abnormal alpha-catenin expression in invasive breast cancer correlates with poor patient survival.

Authors:  L Nakopoulou; H Gakiopoulou-Givalou; A J Karayiannakis; I Giannopoulou; A Keramopoulos; P Davaris; M Pignatelli
Journal:  Histopathology       Date:  2002-06       Impact factor: 5.087

7.  Tumor-specific downregulation and methylation of the CDH13 (H-cadherin) and CDH1 (E-cadherin) genes correlate with aggressiveness of human pituitary adenomas.

Authors:  Zhi Rong Qian; Toshiaki Sano; Katsuhiko Yoshimoto; Sylvia L Asa; Shozo Yamada; Noriko Mizusawa; Eiji Kudo
Journal:  Mod Pathol       Date:  2007-09-14       Impact factor: 7.842

Review 8.  Altered expression of the catenin p120 in human cancer: implications for tumor progression.

Authors:  Molly A Thoreson; Albert B Reynolds
Journal:  Differentiation       Date:  2002-12       Impact factor: 3.880

9.  Expression of p120, Ki-67 and PCNA as proliferation biomarkers in imprint smears of prostate carcinoma and their prognostic value.

Authors:  A Bantis; A Giannopoulos; M Gonidi; A Liossi; E Aggelonidou; E Petrakakou; P Athanassiades; P Athanassiadou
Journal:  Cytopathology       Date:  2004-02       Impact factor: 2.073

10.  Regulation of p120-catenin nucleocytoplasmic shuttling activity.

Authors:  Agnes Roczniak-Ferguson; Albert B Reynolds
Journal:  J Cell Sci       Date:  2003-09-02       Impact factor: 5.285

View more
  8 in total

1.  In vitro treatment of carcinoma cell lines with pancreatic (pro)enzymes suppresses the EMT programme and promotes cell differentiation.

Authors:  Macarena Perán; Juan Antonio Marchal; Maria A García; Julian Kenyon; David Tosh
Journal:  Cell Oncol (Dordr)       Date:  2013-05-16       Impact factor: 6.730

Review 2.  Molecular diagnosis of intrahepatic cholangiocarcinoma.

Authors:  Hiroaki Haga; Tushar Patel
Journal:  J Hepatobiliary Pancreat Sci       Date:  2014-09-29       Impact factor: 7.027

3.  Altered expression of p120catenin predicts poor outcome in invasive breast cancer.

Authors:  K Talvinen; J Tuikkala; M Nykänen; A Nieminen; J Anttinen; O S Nevalainen; S Hurme; T Kuopio; P Kronqvist
Journal:  J Cancer Res Clin Oncol       Date:  2010-02-12       Impact factor: 4.553

4.  c-Crk proto-oncogene contributes to transcriptional repression of p120-catenin in non-small cell lung cancer cells.

Authors:  Fariborz Mortazavi; Steven Dubinett; Matthew Rettig
Journal:  Clin Exp Metastasis       Date:  2011-02-20       Impact factor: 5.150

5.  Altered localization of p120 catenin in the cytoplasm rather than the membrane correlates with poor prognosis in esophageal squamous cell carcinoma.

Authors:  Tian Chen; Chen Wang; Fang Wu; Xuebang Zhang; Han Yang; Xia Deng; Qiancheng He; Wenfeng Li; Gang Li
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

6.  Periostin promotes malignant potential by induction of epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma.

Authors:  Masaaki Mino; Keishi Kanno; Kousuke Okimoto; Akiko Sugiyama; Nobusuke Kishikawa; Tomoki Kobayashi; Junya Ono; Kenji Izuhara; Tsuyoshi Kobayashi; Toshikazu Ohigashi; Hideki Ohdan; Susumu Tazuma
Journal:  Hepatol Commun       Date:  2017-10-25

7.  p120-Catenin Is Required for Dietary Calcium Suppression of Oral Carcinogenesis in Mice.

Authors:  Zhongjian Xie; Yuan Yuan; Yi Jiang; Chandrama Shrestha; Ying Chen; Liyan Liao; Shangli Ji; Xiaoge Deng; Eryuan Liao; Daniel D Bikle
Journal:  J Cell Physiol       Date:  2016-11-10       Impact factor: 6.384

8.  PAK1 kinase promotes cell motility and invasiveness through CRK-II serine phosphorylation in non-small cell lung cancer cells.

Authors:  Matthew Rettig; Kenny Trinidad; G Pezeshkpour; Patrick Frost; Sherven Sharma; Farhad Moatamed; Fuyuhiko Tamanoi; Fariborz Mortazavi
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.